Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 11, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 7R6W | P0DTC2 | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab | |
| 7R6X | P0DTC2 | SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab | |
| 7R7N | P0DTC2 | SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of the RBD and S2D106) | |
| 7R8L | P0DTC2 | Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022 | |
| 7R8M | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032 | |
| 7R8N | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051 | |
| 7R8O | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548 | |
| 7RA8 | P0DTC2 | SARS-CoV-2 S glycoprotein in complex with S2X259 Fab | |
| 7RAL | P0DTC2 | SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains) | |
| 7RW2 | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7D6I | P0DTC2 | A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2 | |
| 7EKH | P0DTC2 | Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 | |
| 7MZK | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 | |
| 7MZM | P0DTC2 | SARS-CoV-2 receptor binding domain bound to Fab PDI 215 | |
| 7N5H | P0DTC2 | Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7SOD | P0DTC2 | SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement | |
| 7SY0 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
| 7V7E | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1 | |
| 7V83 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
| 7V84 | P0DTC2 | Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V85 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V86 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form | |
| 7V87 | P0DTC2 | Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V88 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, two ACE2-bound form | |
| 7V89 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 1 | |
| 7V8A | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain, three ACE2-bound form conformation 2 | |
| 7V8B | P0DTC2 | Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7V8C | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation | |
| 7VNB | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113 | |
| 7VNC | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1) | |
| 7VND | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2) | |
| 7VNE | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state) | |
| 7VX4 | P0DTC2 | ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex | |
| 7VX5 | P0DTC2 | ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex | |
| 8FU7 | P0DTC2 | Structure of Covid Spike variant deltaN135 in fully closed form | |
| 8FU8 | P0DTC2 | Structure of Covid Spike variant deltaN135 with one erect RBD | |
| 8FU9 | P0DTC2 | Structure of Covid Spike variant deltaN25 with one erect RBD | |
| 8GJM | P0DTC2 | 17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer | |
| 8GJN | P0DTC2 | 17B10 fab in complex with up-RBD of SARS-CoV-2 Spike G614 trimer | |
| 7XIL | P0DTC2 | SARS-CoV-2-Beta-RBD and B38-GWP/P-VK antibody complex | |
| 7XS8 | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-1H1 Fab | |
| 8HEB | P0DTC2 | SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation | |
| 8HEC | P0DTC2 | SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation | |
| 8HED | P0DTC2 | Local refinement of the SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab | |
| 7Y20 | P0DTC2 | S-ECD (Omicron BA.3) in complex with two PD of ACE2 | |
| 7Y21 | P0DTC2 | S-ECD (Omicron BA.5) in complex with PD of ACE2 | |
| 7YBH | P0DTC2 | SARS-CoV-2 lambda variant spike | |
| 7YBL | P0DTC2 | SARS-CoV-2 B.1.620 variant spike (close state) | |
| 7YBM | P0DTC2 | SARS-CoV-2 C.1.2 variant spike (Close state) | |
| 8GF2 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3 |
